Facebook Pixel The Revival Of Pharma MSMES | Express Pharma – Health – Lesen Sie diese Geschichte auf Magzter.com

Versuchen GOLD - Frei

The Revival Of Pharma MSMES

Express Pharma

|

December 16-31, 2018

Effective implementation of the recently launched MSME Support and Outreach Programme could prove to be the catalyst for the sector's progress

- Swati Rana

The Revival Of Pharma MSMES

The Modi government recently launched theMSME Support and Outreach Programme to boost the growth of the sector in India. Under the programme, the government has made various announcements and deliverables that focus on access to credit, access to market, hand holding and facilitation support measures etc. for the MSME sector.

The 12 point agenda With the launch of the programme, the government has also announced 12 point agenda for MSMEs. In its announcement, Prime Minister Narendra Modi said, “To resolve the issue of cash cycle in MSMEs, all companies with a turnover more than 500 crores, must now compulsorily be brought on the Trade Receivables e-Discounting System (TReDS). Joining this portal will enable entrepreneurs to access credit from banks, based on their upcoming receivables.”

1) Launch of 59-minute loan portal to enable easy access to credit for MSMEs. In principle approval of loans upto 1 crore through the portal. Portal link through GST portal.

2) Two per cent interest subvention for all GST registered MSMEs, on fresh or incremental loans. Increase in interest rebate from three to five per cent for exporters who receive loans in the pre-shipment and post-shipment period.

3) Companies with turnover more than 500 crores to be compulsorily brought on the Trade Receivables e-Discounting System (TReDS) to enable entrepreneurs to access credit, based on upcoming receivables.

4) Central Public Sector Undertaking (CPSUs) units to make mandatory procurement of 25 per cent instead of 205 from MSMEs.

5) CPSUs to make mandatory procurement of three per cent from women entrepreneurs out of 25 per cent mandatory procurement.

6) CPSUs to compulsorily be part of Public Procurement Portal GeM- Government e-Marketplace. CPSUs to get their vendors registered on GeM portal.

WEITERE GESCHICHTEN VON Express Pharma

Express Pharma

Express Pharma

Glass vs other pharma packaging materials: Safeguarding purity, enhancing trust

Rajesh Khosla, CEO, AGI Greenpac explains why glass stands out as a trusted material that continues to meet modern pharma's safety and sustainability demands

time to read

3 mins

March 2026

Express Pharma

Express Pharma

WHEN She LEADS

Women shaping pharma today share honest lessons and real-world leadership wisdom for the next generation of women who dare to lead

time to read

15 mins

March 2026

Express Pharma

Express Pharma

Our approach is to combine localised production with global quality standards

Jean Charles Wirth, Global CEO of Merck Life Science, shares insights on the company's approach in a price conscious and quality focused market like India, the company's close alignment with the 'Make in India' vision and how Merck is fostering scientific talent to support customers in India, the Asia-Pacific region, and globally, in an interaction with Viveka Roychowdhury

time to read

3 mins

March 2026

Express Pharma

Express Pharma

India has the infrastructure to lead the global gene therapy market

Professor Philip J. Young, Director of Educational Analytics, School of Life Sciences, University of Warwick, outlines how AI is compressing drug discovery timelines, why affordability remains the real bottleneck in SMA care, and how India can lead the next phase of precision medicine, in an exclusive interview with Neha Aathavale

time to read

8 mins

March 2026

Express Pharma

Express Pharma

Industrial and infrastructure sectors are undergoing rapid modernisation

In the pharma sector, precision is non-negotiable and compliance is constant. Attention often focuses on formulations and manufacturing processes; yet the foundation of operational excellence lies in infrastructure - the systems that quietly ensure safety, efficiency and regulatory adherence. Jinali Gandhi, Director at Gandhi Automations, represents a new generation of leaders shaping this critical dimension of the industry

time to read

2 mins

March 2026

Express Pharma

Express Pharma

Targeted incentives for innovation-driven research would further strengthen India's biotech ecosystem

Venkat Nelabhotla, Co-Founder, President and CEO of Vyome Holdings, shares how focused innovation, disciplined development and policy support can accelerate India's emergence as a global biotech innovation hub, in an interview with Lakshmipriya Nair

time to read

3 mins

March 2026

Express Pharma

Express Pharma

Partners in Progress: PPL 2026

PPL 2026 brought together India's pharma packaging ecosystem to explore how collaboration, innovation, and technical expertise can strengthen patient safety, product stability, and operational efficiency. Across partner-led sessions, speakers discussed how structured systems, material science, regulatory alignment, and technology integration collectively elevate packaging from a support function to a strategic enabler.

time to read

2 mins

March 2026

Express Pharma

Express Pharma

What truly differentiates Transchem is our technical-first approach

Sanjay Lanke, VP - Technical Business Development, Transchem Corporation Pharma, outlines its focus on innovation, strategic partnerships, and portfolio diversification to support complex formulations while expanding its presence across pharma, nutraceutical, and food ingredient markets, in an interview with Lakshmipriya Nair

time to read

3 mins

March 2026

Express Pharma

Express Pharma

Tech, trust and traceability: Shaping India pharma's future

At the PPL Conclave 2026, hosted by Express Pharma, industry leaders explored how innovation, operational excellence and evolving regulations are positioning packaging as a strategic driver in India's pharma growth, reports Neha Aathavale

time to read

7 mins

March 2026

Express Pharma

Express Pharma

In 2026, India serves as the reliable 'technical engine' for global research

Dr Seema Pai, President, Indian Society for Clinical Research outlines how India's clinical research landscape is evolving into a quality-driven, innovation-led ecosystem, supported by regulatory progress, digital adoption, and stronger patient-centric approaches positioning the country as a global research hub, in an interview with Swati Rana

time to read

6 mins

March 2026

Translate

Share

-
+

Change font size